Ironwood Pharmaceuticals (IRWD) Competitors $4.21 +0.10 (+2.43%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IRWD vs. IGMS, CYRX, ZNTL, KURA, GERN, LGND, MNKD, DVAX, CLDX, and BCRXShould you be buying Ironwood Pharmaceuticals stock or one of its competitors? The main competitors of Ironwood Pharmaceuticals include IGM Biosciences (IGMS), Cryoport (CYRX), Zentalis Pharmaceuticals (ZNTL), Kura Oncology (KURA), Geron (GERN), Ligand Pharmaceuticals (LGND), MannKind (MNKD), Dynavax Technologies (DVAX), Celldex Therapeutics (CLDX), and BioCryst Pharmaceuticals (BCRX). Ironwood Pharmaceuticals vs. IGM Biosciences Cryoport Zentalis Pharmaceuticals Kura Oncology Geron Ligand Pharmaceuticals MannKind Dynavax Technologies Celldex Therapeutics BioCryst Pharmaceuticals IGM Biosciences (NASDAQ:IGMS) and Ironwood Pharmaceuticals (NASDAQ:IRWD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation. Is IGMS or IRWD more profitable? Ironwood Pharmaceuticals has a net margin of -0.65% compared to IGM Biosciences' net margin of -7,534.03%. Ironwood Pharmaceuticals' return on equity of -0.96% beat IGM Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets IGM Biosciences-7,534.03% -155.42% -61.04% Ironwood Pharmaceuticals -0.65%-0.96%0.74% Which has higher valuation and earnings, IGMS or IRWD? IGM Biosciences has higher earnings, but lower revenue than Ironwood Pharmaceuticals. Ironwood Pharmaceuticals is trading at a lower price-to-earnings ratio than IGM Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIGM Biosciences$2.13M263.74-$246.42M-$3.64-2.60Ironwood Pharmaceuticals$442.73M1.52-$1.00B-$0.03-140.33 Which has more risk & volatility, IGMS or IRWD? IGM Biosciences has a beta of 0.2, indicating that its stock price is 80% less volatile than the S&P 500. Comparatively, Ironwood Pharmaceuticals has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Do analysts prefer IGMS or IRWD? IGM Biosciences currently has a consensus price target of $16.13, suggesting a potential upside of 70.27%. Ironwood Pharmaceuticals has a consensus price target of $10.40, suggesting a potential upside of 147.03%. Given Ironwood Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Ironwood Pharmaceuticals is more favorable than IGM Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IGM Biosciences 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.38Ironwood Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals and insiders hold more shares of IGMS or IRWD? 42.8% of IGM Biosciences shares are held by institutional investors. 57.0% of IGM Biosciences shares are held by insiders. Comparatively, 12.9% of Ironwood Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to IGMS or IRWD? In the previous week, Ironwood Pharmaceuticals had 7 more articles in the media than IGM Biosciences. MarketBeat recorded 14 mentions for Ironwood Pharmaceuticals and 7 mentions for IGM Biosciences. Ironwood Pharmaceuticals' average media sentiment score of 0.38 beat IGM Biosciences' score of 0.11 indicating that Ironwood Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IGM Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ironwood Pharmaceuticals 2 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer IGMS or IRWD? Ironwood Pharmaceuticals received 439 more outperform votes than IGM Biosciences when rated by MarketBeat users. Likewise, 61.08% of users gave Ironwood Pharmaceuticals an outperform vote while only 50.35% of users gave IGM Biosciences an outperform vote. CompanyUnderperformOutperformIGM BiosciencesOutperform Votes7150.35% Underperform Votes7049.65% Ironwood PharmaceuticalsOutperform Votes51061.08% Underperform Votes32538.92% SummaryIronwood Pharmaceuticals beats IGM Biosciences on 12 of the 18 factors compared between the two stocks. Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRWD vs. The Competition Export to ExcelMetricIronwood PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$672.50M$6.49B$5.13B$8.74BDividend YieldN/A8.15%5.18%4.07%P/E Ratio-140.334.8266.7313.27Price / Sales1.52374.171,265.2981.14Price / CashN/A51.8140.2135.77Price / Book-2.169.636.455.92Net Income-$1.00B$154.43M$119.73M$225.73M7 Day Performance-15.12%-9.46%-5.13%-1.34%1 Month Performance-5.18%-7.27%-2.71%1.15%1 Year Performance-56.95%28.13%31.08%24.02% Ironwood Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRWDIronwood Pharmaceuticals4.2073 of 5 stars$4.21+2.4%$10.40+147.0%-55.4%$672.50M$442.73M-140.33220Analyst DowngradeShort Interest ↓IGMSIGM Biosciences4.6905 of 5 stars$11.35-11.9%N/A+64.4%$764.02M$2.13M-3.12190Earnings ReportShort Interest ↓CYRXCryoport2.7246 of 5 stars$7.95-1.0%N/A-47.7%$396.93M$233.26M-2.351,170High Trading VolumeZNTLZentalis Pharmaceuticals2.454 of 5 stars$3.71-7.9%N/A-69.1%$286.57MN/A-1.36160Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageKURAKura Oncology4.1044 of 5 stars$18.57+5.8%N/A+75.1%$1.37BN/A-7.87142Analyst UpgradeShort Interest ↑High Trading VolumeGERNGeron3.5208 of 5 stars$3.97-3.6%N/A+95.7%$2.49B$240,000.00-12.41141LGNDLigand Pharmaceuticals4.9911 of 5 stars$120.74-2.2%N/A+95.5%$2.33B$131.31M48.1080Analyst ForecastMNKDMannKind3.9359 of 5 stars$7.08-1.9%N/A+88.9%$1.99B$198.96M101.14400DVAXDynavax Technologies4.6463 of 5 stars$13.50-1.2%N/A-9.8%$1.80B$232.28M103.85408Short Interest ↑CLDXCelldex Therapeutics2.7989 of 5 stars$27.01+3.1%N/A-15.3%$1.74B$6.88M-10.51160Insider BuyingBCRXBioCryst Pharmaceuticals4.2114 of 5 stars$7.82-4.5%N/A+36.8%$1.62B$331.41M-12.82530Short Interest ↓ Related Companies and Tools Related Companies IGM Biosciences Alternatives Cryoport Alternatives Zentalis Pharmaceuticals Alternatives Kura Oncology Alternatives Geron Alternatives Ligand Pharmaceuticals Alternatives MannKind Alternatives Dynavax Technologies Alternatives Celldex Therapeutics Alternatives BioCryst Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRWD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRWD Stock Alerts